Product Information

What is CJC-1295 No DAC?

CJC-1295 No DAC is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), a naturally occurring hormone produced by the hypothalamus. Its purpose is to stimulate the pituitary gland to release the body's own natural growth hormone.

Unlike synthetic growth hormone itself, CJC-1295 No DAC does not replace or supply growth hormone. Instead, it works by activating the body's own signalling pathways, encouraging the pituitary gland to release endogenous growth hormone through normal receptor activation.

CJC-1295 No DAC has become one of the best recognised GHRH analogues because of its receptor specificity, predictable pharmacological profile and shorter duration of action compared with the DAC version.

Whether you are searching for CJC-1295 No DAC in the Philippines or looking to better understand how this peptide works, it remains one of the most widely discussed compounds within the GHRH analogue category.

Why Do People Use CJC-1295 No DAC?

In simple terms, CJC-1295 No DAC is used because it encourages the body to release more of its own natural growth hormone.

Growth hormone is involved in many normal biological processes throughout the body. It plays a role in muscle protein synthesis, tissue repair, recovery following exercise, normal metabolism, sleep quality, body composition and the production of Insulin-like Growth Factor 1 (IGF-1).

Because CJC-1295 No DAC stimulates the body's own growth hormone release rather than supplying growth hormone directly, it has attracted significant interest among people seeking a compound that works with the body's existing endocrine signalling pathways.

One of the reasons many people specifically choose the No DAC version is its shorter duration of action. Rather than remaining active for several days, it produces a shorter period of receptor stimulation that more closely resembles the body's normal pattern of hormone release.

For many people, that distinction is one of the defining features separating CJC-1295 No DAC from its longer-acting counterpart.

How Does CJC-1295 No DAC Work?

The body naturally produces Growth Hormone Releasing Hormone within the hypothalamus.

This hormone travels to the anterior pituitary where it binds to specialised receptors responsible for initiating growth hormone secretion.

CJC-1295 No DAC has been designed to interact with these same receptors.

Once receptor activation occurs, the pituitary gland releases endogenous growth hormone.

Following this release, growth hormone travels throughout the body and also stimulates the production of Insulin-like Growth Factor 1 (IGF-1), another important signalling molecule involved in growth hormone physiology.

Unlike injecting growth hormone itself, CJC-1295 No DAC works further upstream within the endocrine system by encouraging the body's own natural hormonal signalling pathways.

This mechanism is one of the primary reasons CJC-1295 No DAC has remained such a well-known peptide for many years.

CJC-1295 No DAC vs CJC-1295 with DAC

Although the names are very similar, these are two distinct products.

The Drug Affinity Complex (DAC) was developed to dramatically extend how long CJC-1295 remains active within the body.

Removing DAC creates a peptide with a much shorter duration of action.

This means CJC-1295 No DAC produces a shorter period of receptor stimulation before gradually being cleared.

Many people specifically seek the No DAC version because they prefer the shorter pharmacological profile rather than prolonged receptor activation.

Understanding this difference is important because the presence or absence of DAC fundamentally changes how each peptide behaves.

Product Specifications

Product Name

CJC-1295 No DAC

Strength

5mg

Compound Type

Synthetic Growth Hormone Releasing Hormone analogue.

Presentation

Lyophilised powder supplied in a sterile glass vial.

Growth Hormone Physiology

Growth hormone is naturally produced throughout life.

Rather than being released continuously, secretion normally occurs in pulses throughout both the day and night.

These pulses are regulated by a complex interaction between Growth Hormone Releasing Hormone, somatostatin and several additional signalling pathways.

Because CJC-1295 No DAC stimulates Growth Hormone Releasing Hormone receptors, its activity begins at the very start of this natural endocrine pathway.

This differs significantly from administering growth hormone directly, as endogenous secretion remains dependent upon the body's own physiological mechanisms.

The Role of IGF-1

One of the downstream effects of growth hormone release is stimulation of Insulin-like Growth Factor 1 production.

IGF-1 is produced primarily by the liver and acts throughout numerous tissues within the body.

The relationship between Growth Hormone Releasing Hormone, growth hormone and IGF-1 represents one of the most extensively characterised hormonal pathways within endocrinology.

Because CJC-1295 No DAC activates the beginning of this pathway, it continues to attract widespread interest among those seeking to better understand normal growth hormone physiology.

Pharmacological Profile

One of the defining characteristics of CJC-1295 No DAC is its receptor specificity.

Rather than interacting broadly with multiple hormone systems, CJC-1295 No DAC is designed to activate Growth Hormone Releasing Hormone receptors located within the anterior pituitary.

Its relatively short half-life distinguishes it from CJC-1295 with DAC, allowing receptor stimulation to occur over a shorter period before the peptide is naturally cleared.

Because of these characteristics, CJC-1295 No DAC has become one of the most recognised peptides within the GHRH analogue category.

Peptide Structure

Like many modern peptide compounds, CJC-1295 No DAC is supplied as a lyophilised powder.

Lyophilisation is a freeze-drying process that removes moisture while helping preserve peptide stability during storage and transport.

This presentation allows the peptide to remain stable for considerably longer before reconstitution than it would in liquid form.

Once reconstituted, appropriate refrigerated storage is generally recommended to help maintain stability.

Storage Recommendations

For maximum stability, unopened vials are generally recommended to be stored between 2°C and 8°C.

For longer-term storage, unopened lyophilised peptides may also be frozen provided repeated freeze-thaw cycles are avoided.

Following reconstitution, refrigeration is recommended.

Avoid unnecessary exposure to heat, direct sunlight and repeated temperature fluctuations.

Maintaining stable storage conditions helps preserve peptide integrity.

Reconstitution

CJC-1295 No DAC is commonly reconstituted using bacteriostatic water.

The diluent is generally introduced slowly against the inside wall of the vial.

Allow the powder to dissolve naturally before gently swirling until the solution becomes clear.

Avoid vigorous shaking, as unnecessary agitation may affect delicate peptide structures.

The volume of diluent used depends upon the concentration required.

Quality and Presentation

Every vial is supplied as a sterile lyophilised powder in a glass vial designed to protect the contents during storage and transport.

Products are clearly identified and carefully packaged before dispatch to minimise the risk of damage during shipping.

Protective packaging is used to help ensure products arrive in excellent condition.

Scientific Understanding

Over the past two decades, CJC-1295 No DAC has become one of the most widely recognised GHRH analogue peptides.

Its mechanism of action, receptor specificity and predictable pharmacological profile have resulted in extensive published literature discussing endocrine physiology, peptide pharmacology and hormonal signalling.

As understanding of peptide science has continued to develop, CJC-1295 No DAC has remained one of the reference compounds within its category.

Common Questions

Is CJC-1295 No DAC the same as growth hormone?

No.

CJC-1295 No DAC does not contain growth hormone.

Instead, it encourages the pituitary gland to release the body's own endogenous growth hormone through activation of Growth Hormone Releasing Hormone receptors.

Why do some people choose the No DAC version?

The primary reason is its shorter duration of action.

Without the Drug Affinity Complex, receptor activation occurs over a much shorter period than with the DAC version.

This difference has made both products popular for different purposes.

What does GHRH stand for?

GHRH stands for Growth Hormone Releasing Hormone.

It is the naturally occurring hormone responsible for signalling the pituitary gland to release growth hormone.

What does lyophilised mean?

Lyophilised simply means freeze-dried.

Removing water helps improve peptide stability before reconstitution and allows the product to be stored for longer under appropriate conditions.

Why CJC-1295 No DAC Continues to Be Popular

CJC-1295 No DAC remains one of the best-known peptides within the Growth Hormone Releasing Hormone analogue category.

Its ability to stimulate endogenous growth hormone release through normal receptor pathways, together with its shorter pharmacological profile, has contributed to its ongoing popularity.

Customers searching for CJC-1295 No DAC Philippines, CJC-1295 No DAC 5mg, GHRH peptide, Growth Hormone Releasing Hormone analogue or premium CJC-1295 No DAC are often looking for a compound with well-established pharmacology and a clearly understood mechanism of action.

Whether you are learning about CJC-1295 No DAC for the first time or comparing it with the DAC version, understanding how the peptide interacts with the body's natural hormone signalling pathways provides valuable context for appreciating why it remains one of the most recognised compounds within peptide science.

Additional information regarding shipping, delivery and product documentation can be found within the remaining sections of this product page.

For research purposes only. Not intended for human consumption or therapeutic use.